Cost-effectiveness of a primary care model for anxiety disorders.
Standard
Cost-effectiveness of a primary care model for anxiety disorders. / König, Hans-Helmut; Born, Anja; Heider, Dirk; Matschinger, Herbert; Heinrich, Sven; Riedel-Heller, Steffi G; Surall, Daniel; Angermeyer, Matthias C; Roick, Christiane.
in: BRIT J PSYCHIAT, Jahrgang 195, Nr. 4, 4, 2009, S. 308-317.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Cost-effectiveness of a primary care model for anxiety disorders.
AU - König, Hans-Helmut
AU - Born, Anja
AU - Heider, Dirk
AU - Matschinger, Herbert
AU - Heinrich, Sven
AU - Riedel-Heller, Steffi G
AU - Surall, Daniel
AU - Angermeyer, Matthias C
AU - Roick, Christiane
PY - 2009
Y1 - 2009
N2 - BACKGROUND: Individuals with anxiety disorders often do not receive an accurate diagnosis or adequate treatment in primary care. AIMS: To analyse the cost-effectiveness of an optimised care model for people with anxiety disorders in primary care. METHOD: In a cluster randomised controlled trial, 46 primary care practices with 389 individuals positively screened with anxiety were randomised to intervention (23 practices, 201 participants) or usual care (23 practices, 188 participants). Physicians in the intervention group received training on diagnosis and treatment of anxiety disorders combined with the offer of a psychiatric consultation-liaison service for 6 months. Anxiety, depression, quality of life, service utilisation and costs were assessed at baseline, 6-month and 9-month follow-up. RESULTS: No significant differences were observed between intervention and control group on the Beck Anxiety Inventory, Beck Depression Inventory and EQ-5D during follow-up. Total costs were higher in the intervention group (euro4911 v. euro3453, P = 0.09). The probability of an incremental cost-effectiveness ratio
AB - BACKGROUND: Individuals with anxiety disorders often do not receive an accurate diagnosis or adequate treatment in primary care. AIMS: To analyse the cost-effectiveness of an optimised care model for people with anxiety disorders in primary care. METHOD: In a cluster randomised controlled trial, 46 primary care practices with 389 individuals positively screened with anxiety were randomised to intervention (23 practices, 201 participants) or usual care (23 practices, 188 participants). Physicians in the intervention group received training on diagnosis and treatment of anxiety disorders combined with the offer of a psychiatric consultation-liaison service for 6 months. Anxiety, depression, quality of life, service utilisation and costs were assessed at baseline, 6-month and 9-month follow-up. RESULTS: No significant differences were observed between intervention and control group on the Beck Anxiety Inventory, Beck Depression Inventory and EQ-5D during follow-up. Total costs were higher in the intervention group (euro4911 v. euro3453, P = 0.09). The probability of an incremental cost-effectiveness ratio
KW - Adult
KW - Germany
KW - Humans
KW - Aged
KW - Middle Aged
KW - Practice Guidelines as Topic
KW - Psychiatric Status Rating Scales
KW - Adolescent
KW - Anxiety Disorders economics
KW - Cognitive Therapy economics
KW - Cost-Benefit Analysis
KW - Family Practice economics
KW - Primary Health Care economics
KW - Quality of Life
KW - Questionnaires
KW - Referral and Consultation
KW - Young Adult
KW - Adult
KW - Germany
KW - Humans
KW - Aged
KW - Middle Aged
KW - Practice Guidelines as Topic
KW - Psychiatric Status Rating Scales
KW - Adolescent
KW - Anxiety Disorders economics
KW - Cognitive Therapy economics
KW - Cost-Benefit Analysis
KW - Family Practice economics
KW - Primary Health Care economics
KW - Quality of Life
KW - Questionnaires
KW - Referral and Consultation
KW - Young Adult
M3 - SCORING: Zeitschriftenaufsatz
VL - 195
SP - 308
EP - 317
JO - BRIT J PSYCHIAT
JF - BRIT J PSYCHIAT
SN - 0007-1250
IS - 4
M1 - 4
ER -
